期刊文献+

雷公藤内酯醇洗脱支架抑制小型猪冠脉再狭窄研究 被引量:2

The Effect and Mechanism of Triptolide-eluting Stent on Preventing Porcine Coronary Restenosis In Miniwine
下载PDF
导出
摘要 目的评价雷公藤内酯醇洗脱支架对预防小型猪冠状动脉模型再狭窄的疗效,研究其量效关系与安全性。方法将30只西藏小型猪分为不锈钢裸金属支架组、雷帕霉素支架组、雷公藤内酯醇60μg支架组、雷公藤内酯醇100μg支架组和雷公藤内酯醇200μg支架组等5组,设立7d组和28d组两个观察终点。每只猪选择左前降支和右冠脉分别置入同一类型支架各1枚。共置入支架60枚。28d组于术后28d行冠状动脉造影,术后处死动物,取出支架血管,行病理组织学分析。7d组于术后7d处死动物,取支架血管行核因子NF-κB免疫组化检测。所有小型猪术前术后行血常规和血肝肾功能检查。结果支架植入后28d组、雷公藤内酯醇100μg支架组和雷帕霉素支架组最小内径相似(P>0.05),均大于不锈钢裸金属支架组(P<0.05)。雷公藤内酯醇100μg支架组与雷帕霉素支架组相比新生内膜厚度相似(P>0.05),均明显小于不锈钢裸金属支架组、雷公藤内酯醇60μg支架组和雷公藤内酯醇200μg支架组(P<0.05)。雷公藤内酯醇100μg支架组与雷帕霉素支架组相比狭窄程度相似(P>0.05),均明显小于不锈钢裸金属支架组、雷公藤内酯醇60μg支架组和雷公藤内酯醇200μg支架组(P<0.05)。支架植入后雷公藤内酯醇100μg支架组NF-κB阳性细胞数比不锈钢裸金属支架组、雷帕霉素支架组、雷公藤内酯醇60μg支架组和雷公藤内酯醇200μg支架组减少(P<0.05),其它4组无统计学意义(P>0.05)。结论雷公藤内酯醇支架能抑制冠脉内膜增生,在支架植入4周内能预防再狭窄,无毒副作用,且其效应呈剂量依赖性。 Objective To evaluate the effect of triptolide eluting- stent on preventing in- stent restenosis in mini porcine models, and to investigate it's dose-effect relationship and safety. Methods 30 Tibet mini porcine were randomly divided into five groups: bare metal stent group, rapamycin-eluting stent group, triptolide-eluting stent 60μg group, triptolide-eluting stent 100 μg group and triptolide-eluting stent 200 μg group. And two observe end points respectively 7 days and 28 days were set. Each of the animals was implanted one same-type stent into left anterior descending coronary (LAD) and right coronary artery (RCA) re- spectively. Those animals which observe end point is 28 clays were performed coronary angiography and executed in the 28th day after implantation. And the stent implanted arteries were histopathology and histomorphometry analyzed. Those animals which observe end point is 7 days were also executed in the 7^th day after the implantation. And immunocytochemistry analysis was performed to detect the expression NF-κB ( nuclear factor-κB) protein in the stent implanted arteries. Functional parameters of liver and renal (ALT, AST and CREA) in all animals were checked before the implantation and when the animals were executed. Results In the 28 days groups, the in-stent minimal lumen diameter of the rapamycin eluting- stent group was similar to that of triptolide ehuting-stent 100 μg group ( P 〉 0.05 ), both of which were larger than that of bare metal stent group ( P 〈 0.05 ). The neointimal area of the troptolide eluting-stent 100 μg group was similar to that of rapamycin eluting- stent group ( P 〉0.05 ), both of which were apparently smaller than the orther three groups (P 〈0.05 ). The lumen stenosis rate of the troptolide eluting-stent 100 μg group was similar to that of rapam- ycin eluting- stent group ( P 〉 0.05 ), both of which were apparently smaller than the orther three groups ( P 〈 0.05). Immunocytochemistry analysis results showed that compare with bare metal stent group, rapamycin eluting- stent group , troptolide eluting- stent 60 μg and 200μg group the expression of NF-κB protein was less in the troptolide eluting- stent 100 μg group ( P 〈 0.05 ) ; and compare with each other the expression of NF- κB protein in the first four groups was no statistic significance. Conclusion Troptolide eluting- stent can inhibit the proliferation of intimal, and exhibits a dose dependent effect on preventing in- stent restenosis with- in four weeks after the implantation.
出处 《血栓与止血学》 2008年第6期246-249,253,共5页 Chinese Journal of Thrombosis and Hemostasis
基金 广州市科技局立项课题 项目编号(2007Z3-E0131) 广东省中医药管理局 项目编号(303005002) 广东省科技厅 项目编号(2005B33101012)
关键词 再狭窄 药物洗脱支架 雷公藤内酯醇 Restenosis Drug eluting stent Triptolide
  • 相关文献

参考文献13

  • 1[1]FISCHMAN DL.A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease.Stent Restenosis study investigators[J].New England Joura,Medicine,1994,331:496-501.
  • 2[2]SCHWARTZ RS,HUBER KC,MURPHY JG,et al.Restenosis and the proportional neointimal response to coronary artery injury:results in a porcine model[J].J Am Coll Cardiol,1992,19(2):267-274.
  • 3刘威,李昭骥,陆东风.雷公藤内酯醇对血管平滑肌细胞增殖的影响[J].现代中西医结合杂志,2003,12(14):1470-1472. 被引量:8
  • 4陆东风,黄璟,吴昊,原萧,张莉.雷公藤内酯醇洗脱支架抑制支架内再狭窄及对PCNA、P27^(kip1)表达的影响[J].南方医科大学学报,2007,27(5):667-670. 被引量:6
  • 5张莉,陆东风,李妍,黄璟,江中喜.比较雷公藤内酯醇与西罗莫司洗脱支架预防再狭窄[J].岭南心血管病杂志,2007,13(4):296-298. 被引量:3
  • 6林建峰,朱惠,郑幼兰.雷公藤内酯醇诱导的血栓性浅静脉炎[J].海峡药学,2001,13(3):35-37. 被引量:11
  • 7[7]PFISTERERM,BRUNNER-LA ROCCA HP,et al.Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents:an observational study of drug-eluting versus bare-metal stents[J].J Am Coll Cardiol,2006,48(12):2584-2591.
  • 8[8]JONERM,FINN AV,FARB A,et al.Pathology of drug-eluting stents in humans:delayed healing and late thrombotic risk[J].J Am Coll Cardiol,2006,48(1):193-202.
  • 9[9]WU CH,CHEN CW,CHEN HC,et al.Elucidating the inhibitory mechanisms of magnolol on rat smooth muscle cell proliferation[J].Pharmacol Sci,2005,99(4):392-399.
  • 10[10]BACUERLE PA,BALTIMORE D.NF-κB:ten year after.Cell,1996,87(1):13-20.

二级参考文献28

  • 1岗艳云,张正行.雷公藤及其单体的药理作用研究进展[J].中国药科大学学报,1995,26(4):252-256. 被引量:82
  • 2赵湘,孙建实,金李君,郭俊华.雷公藤内酯醇作用机制研究进展[J].中国中医药科技,2006,13(3):200-204. 被引量:15
  • 3黄璟,陆东风,吴昊,原萧.雷公藤内酯醇洗脱支架对冠状动脉支架内再狭窄的影响[J].岭南心血管病杂志,2006,12(4):298-300. 被引量:7
  • 4汪钟 徐叔云 等.血小板聚集测定法.药理实验方法学(第二版)[M].北京:人民卫生出版社,1991.1121-1123.
  • 5林展 谭基明.血管损伤及止血的病理生理基础.外科病理生理学[M].北京:人民卫生出版社,1998.247-9.
  • 6徐理纳 陈修 等.抗血栓药.心血管药理学(第2版)[M].北京:人民卫生出版社,1997.547-570.
  • 7林建峰 朱惠 等.雷公藤内酯醇引起的局部炎症反应[J].福建医药杂志,1997,19(2):194-194.
  • 8许建华 黄自强.雷公藤内酯对人癌细胞细胞毒作用及癌细胞合成的影响[J].福建医药杂志,1989,1(3):6-6.
  • 9吕联煌.雷公藤内酯醇治疗白血病的研究进展.血液病实验和临床[M].福建省血液病研究所,1991.112-114.
  • 10唐燕 徐叔云 等.血管内皮细胞培养技术.药理实验方法学(第二版)[M].北京:人民卫生出版社,1991.546.

共引文献102

同被引文献59

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部